🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carly Roleder

City Of Hope National Medical Center

ORCID: 0009-0001-9844-0367

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies”.

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Blood Advances(2024)10.1182/bloodadvances.2024014633

N/A

0.420DataRank · unranked

9 citations

Danielle M. Brander, Yesid Alvarado, Catherine Diefenbach, Daniel Nathan Egan, Shira Dinner +14 more

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma

Cell Death and Disease(2022)10.1038/s41419-022-04684-1

N/A

0DataRank · unranked

26 citations

Tingting Liu, Nur Bruss, Carly Roleder, Vi Lam, Xiaoguang Wang +9 more

CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma

Molecular Cancer(2023)10.1186/s12943-023-01762-6

N/A

0DataRank · unranked

36 citations

Nur Bruss, Duanchen Sun, Edward C. Dominguez, Daniel J. Coleman, Tingting Liu +9 more